The DOI matches its Crossref record; 190 of the 192 references it cites were found in a registry or an index.
Pharmacological antioxidant strategies as therapeutic interventions for COPD
Open accessAbstract
Cigarette/tobacco smoke/biomass fuel-induced oxidative and aldehyde/carbonyl stress are intimately associated with the progression and exacerbation of chronic obstructive pulmonary disease (COPD). Therefore, targeting systemic and local oxidative stress with antioxidants/redox modulating agents, or boosting the endogenous levels of antioxidants are likely to have beneficial effects in the treatment/management of COPD. Various antioxidant agents, such as thiol molecules (glutathione and mucolytic drugs, such as N-acetyl-L-cysteine and N-acystelyn, erdosteine, fudosteine, ergothioneine, and carbocysteine), have been reported to modulate various cellular and biochemical aspects of COPD. These antioxidants have been found to scavenge and detoxify free radicals and oxidants, regulate of glutathione biosynthesis, control nuclear factor-kappaB (NF-kappaB) activation, and hence inhibiting inflammatory gene expression. Synthetic molecules, such as specific spin traps like α-phenyl-N-tert-butyl nitrone, a catalytic antioxidant (ECSOD mimetic), porphyrins (AEOL 10150 and AEOL 10113), and a superoxide dismutase mimetic M40419, iNOS and myeloperoxidase inhibitors, lipid peroxidation inhibitors/blockers edaravone, and lazaroids/tirilazad have also been shown to have beneficial effects by inhibiting cigarette smoke-induced inflammatory responses and other carbonyl/oxidative stress-induced cellular alterations. A variety of oxidants, free radicals, and carbonyls/aldehydes are implicated in the pathogenesis of COPD, it is therefore, possible that therapeutic administration or supplementation of multiple antioxidants and/or boosting the endogenous levels of antioxidants will be beneficial in the treatment of COPD. This review discusses various novel pharmacological approaches adopted to enhance lung antioxidant levels, and various emerging beneficial and/or prophylactic effects of antioxidant therapeutics in halting or intervening the progression of COPD. This article is part of a Special Issue entitled: Antioxidants and Antioxidant Treatment in Disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ERG has been found to be an effective antioxidant in cardiovascular diseases (Servillo et al. 2017), chronic pulmonary diseases (Rahman 2012), lung inflammatory diseases (Repine and Elkins 2012), and other pathologies.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Rahman 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Malhotra, D., Thimmulappa, R. K., Navas‐Acién, A., Sandford, A. J., Elliott, M., Singh, A., Chen, L., Zhuang, X., Hogg, J. C., Paré, P. D., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-380oc · Cited by 358
RetractedMalhotra, D., Thimmulappa, R. K., Mercado, N., Ito, K., Kombairaju, P., Kumar, S., Ma, J., Feller-Kopman, D. J., Wise, R. A., Barnes, P. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45144 · Cited by 137
RetractedMuscoli, C., Sacco, I., Alecce, W., Palma, E., Nisticò, R., Costa, N., Clementi, F., Rotiroti, D., Romeo, F., Salvemini, D., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068205 · Cited by 42
RetractedCell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Structure, mechanism and regulation of peroxiredoxins
Wood, Z. A., Schröder, E., Harris, J. R., & Poole, L. B. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)00003-8 · Cited by 2,546
Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., & Ichijo, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2596 · Cited by 2,377
Free-Radical Chemistry of Cigarette Smoke and Its Toxicological Implications
CHURCH, D. F., & PRYOR, W. A. (1985) · Environmental Health Perspectives · doi:10.1289/ehp.8564111 · Cited by 1,442
(2002) · PubMed · Cited by 1,190
Oxidants in Cigarette Smoke Radicals, Hydrogen Peroxide, Peroxynitrate, and Peroxynitritea
Pryor, W. A., & Stone, K. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb39148.x · Cited by 1,179
Balogun, E. A., Hoque, M., Gong, P., Killeen, E., Green, C. J., Foresti, R., Alam, J., & Motterlini, R. (2003) · Biochemical Journal · doi:10.1042/bj20021619 · Cited by 1,038
Flagged first, then by citations
2 of the 192 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Ishibashi, 2001, Effects of carbocisteine on airway inflammation and related events in SO2-exposed rats, Nihon Kokyuki Gakkai Zasshi, 39, 17
- Miskoviti, 1982, Double blind study of carbocysteine against placebo in chronic bronchitis; Mucoregulation in respiratory tract disorders, Proc. R. Soc. Med., 5, 1
- Nagaoka, 2002, Phase III Clinical Study of SS320A. Double-blind Trial in Comparison with Placebo, J. Clin. Ther. Med., 18, 109
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Johnson, N. M., Hoffmann, A. R., Behlen, J. C., Lau, C., Pendleton, D., Harvey, N., Shore, R., Li, Y., Chen, J., Tian, Y., et al. (2021) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-021-00995-5 · Cited by 339
Oxidative stress in apoptosis and cancer: an update
Matés, J. M., Segura, J. A., Alonso, F. J., & Márquez, J. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0906-3 · Cited by 347
Oxidative stress and free radicals in COPD – implications and relevance for treatment
Domej, W., Oettl, K., & Renner, W. (2014) · International Journal of COPD · doi:10.2147/copd.s51226 · Cited by 326
Progress in the mechanism and targeted drug therapy for COPD
Wang, C., Zhou, J., Wang, J., Li, S., Fukunaga, A., Yodoi, J., & Tian, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00345-x · Cited by 321
The biology of ergothioneine, an antioxidant nutraceutical
Borodina, I., Kenny, L. C., McCarthy, C. M., Paramasivan, K., Pretorius, E., Roberts, T. J., van der Hoek, S. A., & Kell, D. B. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422419000301 · Cited by 296
Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms
McGuinness, A., & Sapey, E. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6020021 · Cited by 243
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
Marshall, E. A., Ng, K. W., Kung, S. H. Y., Conway, E. M., Martínez, V. D., Halvorsen, E. C., Rowbotham, D. A., Vucic, E. A., Plumb, A. W., Becker‐Santos, D. D., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0551-1 · Cited by 233
COPD and stroke: are systemic inflammation and oxidative stress the missing links?
Austin, V., Crack, P. J., Bozinovski, S., Miller, A. A., & Vlahos, R. (2016) · Clinical Science · doi:10.1042/cs20160043 · Cited by 193
Grzeszczak, K., Łanocha-Arendarczyk, N., Malinowski, W., Ziętek, P., & Kosik-Bogacka, D. I. (2023) · Biomolecules · doi:10.3390/biom13121768 · Cited by 213
Recent advances in pre-clinical mouse models of COPD
Vlahos, R., & Bozinovski, S. (2013) · Clinical Science · doi:10.1042/cs20130182 · Cited by 159
Selvaraj, V., Nepal, N., Rogers, S., Manne, N. D. P. K., Arvapalli, R., Rice, K. M., Asano, S., Fankhanel, E., Ma, J. J., Shokuhfar, T., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.025 · Cited by 154
Vucic, E. A., Chari, R., Thu, K. L., Wilson, I. M., Cotton, A. M., Kennett, J. Y., Zhang, M., Lonergan, K. M., Steiling, K. A., Brown, C. J., et al. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0304oc · Cited by 155
Rodrigues, S. D. O., da Cunha, C. M. C., Soares, G. M. V., Silva, P. L., Silva, A. R., & Gonçalves-de-Albuquerque, C. F. (2021) · Pharmaceuticals · doi:10.3390/ph14100979 · Cited by 176
COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link
Bozinovski, S., Vlahos, R., Anthony, D., McQualter, J. L., Anderson, G. P., Irving, L. B., & Steinfort, D. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13198 · Cited by 138
Pharmacological Applications of Antioxidants: Lights and Shadows
Saso, L., & Firuzi, O. (2014) · Current Drug Targets · doi:10.2174/1389450115666141024113925 · Cited by 119
Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities
Bernardo, I., Bozinovski, S., & Vlahos, R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.08.005 · Cited by 108
Emerging anti-inflammatory strategies for COPD
Cazzola, M., Page, C. P., Calzetta, L., & Matera, M. G. (2012) · European Respiratory Journal · doi:10.1183/09031936.00213711 · Cited by 107
Hikisz, P., & Jacenik, D. (2023) · Cells · doi:10.3390/cells12060879 · Cited by 102
Oostwoud, L. C., Gunasinghe, P., Seow, H. J., Ye, J. M., Selemidis, S., Bozinovski, S., & Vlahos, R. (2016) · Scientific Reports · doi:10.1038/srep20983 · Cited by 90
Morgillo, F., Dallio, M., Corte, C. M. D., Gravina, A. G., Viscardi, G., Loguercio, C., Ciardiello, F., & Federico, A. (2018) · Neoplasia · doi:10.1016/j.neo.2018.05.002 · Cited by 99
The role of environmental exposure to non‐cigarette smoke in lung disease
Rajendra, K. C., Shukla, S. D., Gautam, S., Hansbro, P. M., & O’Toole, R. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0217-2 · Cited by 84
Acrolein effects in pulmonary cells: relevance to chronic obstructive pulmonary disease
Moretto, N., Volpi, G., Pastore, F., & Facchinetti, F. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06531.x · Cited by 85
Flores, G., Dastmalchi, K., Wu, S., Whalen, K., Dabo, A. J., Reynertson, K. A., Foronjy, R., D'Armiento, J. M., & Kennelly, E. J. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.03.025 · Cited by 81
Selvaraj, V., Manne, N. D. P. K., Arvapalli, R., Rice, K. M., Nandyala, G., Fankenhanel, E., & Blough, E. R. (2015) · Nanomedicine · doi:10.2217/nnm.14.205 · Cited by 68
Shergis, J. L., Di, Y., Zhang, A. L., Vlahos, R., Helliwell, R. M., Ye, J. M., & Xue, C. C. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2014.08.006 · Cited by 69
Asiatic acid inhibits pulmonary inflammation induced by cigarette smoke
Lee, J., Park, H. A., Kwon, O., Jang, Y.-G., Kim, J. Y., Choi, B. K., Lee, H. J., Lee, S.-W., Paik, J., Oh, S., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.07.010 · Cited by 64
Du, Y., Ding, Y., Chen, X., Mei, Z., Ding, H., Wu, Y., & Jie, Z. (2017) · Respiratory Research · doi:10.1186/s12931-017-0639-1 · Cited by 61
Glutathione peroxidase-1 as a novel therapeutic target for COPD
Vlahos, R., & Bozinovski, S. (2013) · Redox Report · doi:10.1179/1351000213y.0000000053 · Cited by 58
Dailah, H. G. (2022) · Molecules · doi:10.3390/molecules27175542 · Cited by 60
Tse, H. N., & Tseng, C. Z. S. (2014) · International Journal of COPD · doi:10.2147/copd.s51057 · Cited by 53
Lung epithelium damage in COPD – An unstoppable pathological event?
Hadžić, S., Wu, C., Avdeev, S. N., Weißmann, N., SCHERMULY, R. T., & Kosanovic, D. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109540 · Cited by 53
Scaglione, F., & Petrini, O. (2019) · Clinical Medicine Insights Ear Nose and Throat · doi:10.1177/1179550618821930 · Cited by 47
Uncovering the Role of Oxidative Imbalance in the Development and Progression of Bronchial Asthma
Vasconcelos, L. H. C., Ferreira, S. R. D., Silva, M. D. C. C., Ferreira, P. B., de Souza, I. L. L., Cavalcante, F. D. A., & da Silva, B. A. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6692110 · Cited by 44
Malerba, M., Nardin, M., Radaeli, A., Montuschi, P., Carpagnano, G. E., & Clini, E. M. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1353416 · Cited by 43
Bishwakarma, R., Zhang, W., Lin, Y., Kuo, Y., Cardenas, V. J., & Sharma, G. (2018) · International Journal of COPD · doi:10.2147/copd.s150047 · Cited by 41
The potential of lipid-polymer nanoparticles as epigenetic and ROS control approaches for COPD
Chikuma, K., Arima, K., Asaba, Y., Kubota, R., Asayama, S., Sato, K., & Kawakami, H. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1696965 · Cited by 39
Astori, E., Garavaglia, M. L., Colombo, G., Landoni, L., Portinaro, N. M., Milzani, A., & Dalle‐Donne, I. (2021) · Nutrition Research Reviews · doi:10.1017/s0954422421000093 · Cited by 43
Shohrati, M., Karimzadeh, I., Saburi, A., Khalili, H., & Ghanei, M. (2014) · Inhalation Toxicology · doi:10.3109/08958378.2014.920439 · Cited by 38
Visalli, G., Baluce, B., Bertuccio, M. P., Picerno, I., & Pietro, A. D. (2015) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2015.1024081 · Cited by 36
Xi, G., & Liu, Z. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.06.059 · Cited by 36
Wang, Y., Wang, Y., Che, H.-J., Jia, Y., Wang, H., Zuo, L.-F., Yang, K., Li, T., & Wang, J. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116020 · Cited by 35
Oxidative/Nitrosative Stress and the Pathobiology of Chronic Obstructive Pulmonary Disease
Pandey, R. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/4360.2832 · Cited by 35
Antioxidants and Chronic Obstructive Pulmonary Disease
Vézina, F.-A., & Cantin, A. M. (2018) · Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation · doi:10.15326/jcopdf.5.4.2018.0133 · Cited by 34
Zhang, H., Sun, D., Li, D., Zheng, Z., Xu, J., Liang, X., Zhang, C., Wang, S., Wang, J., & Lu, W. (2018) · Scientific Reports · doi:10.1038/s41598-018-25702-3 · Cited by 34
Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?
Avcı, E., Sarvari, P., Savai, R., Seeger, W., & Pullamsetti, S. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010546 · Cited by 33
Second hand smoke and COPD: lessons from animal studies
Goldklang, M. P., Marks, S. M., & D'Armiento, J. M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00030 · Cited by 33
Nesi, R. T., de Souza, P. S., Menegalli, B., Silveira, P. C. L., da Silva, L. A., Valença, S. S., Pinho, R. A., dos Santos, G. P., & Thirupathi, A. (2016) · International Journal of COPD · doi:10.2147/copd.s93958 · Cited by 32
Schiffers, C., Reynaert, N. L., Wouters, E. F. �., & van der Vliet, A. (2021) · Antioxidants · doi:10.3390/antiox10111799 · Cited by 31
Oxidative stress-induced autophagy: Role in pulmonary toxicity
Malaviya, R., Laskin, J. D., & Laskin, D. L. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.12.022 · Cited by 30
Heidler, J., Fysikopoulos, A., Wempe, F., Seimetz, M., Bangsow, T., Tomasovic, A., Veit, F., Scheibe, S., Pichl, A., Weisel, F. C., et al. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.013482 · Cited by 28
Nutraceuticals in Respiratory Disorders
Gulati, K., Rai, N., Chaudhary, S., & Ray, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00006-1 · Cited by 30
Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis
Cazzola, M., Calzetta, L., Page, C. P., Rogliani, P., & Matera, M. G. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.11.009 · Cited by 28
Thomson, N. C. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.11.013 · Cited by 28
Design and synthesis of coumarin-3-acylamino derivatives to scavenge radicals and to protect DNA
Yang, Y., Liu, Q., Shi, Y., Song, Z., Jin, Y., & Liu, Z. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.009 · Cited by 27
Li, X., Wan, C.-Q., & Mao, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.979959 · Cited by 27
Cigarette smoke and ozone effect on murine inflammatory responses
Gardi, C., & Valacchi, G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06605.x · Cited by 26
Second hand smoke and COPD: lessons from animal studies
Borchers, M. T., Kratzer, A., & Taraseviciene‐Stewart, L. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00144 · Cited by 25
Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders
Ashique, S., Mishra, N., Mantry, S., Garg, A., Kumar, N., Gupta, M., Kar, S. K., Islam, A., Mohanto, S., & Subramaniyan, V. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03392-1 · Cited by 25
A murine model of elastase- and cigarette smoke-induced emphysema
Rodrigues, R., Olivo, C. R., Lourenço, J. D., Riane, A., Cervilha, D. A. B., Ito, J. T., Martins, M. A., & Lopes, F. D. T. Q. D. S. (2017) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562016000000179 · Cited by 23
Tulen, C. B. M., Opperhuizen, A., van Schooten, F., & Remels, A. H. V. (2023) · Cells · doi:10.3390/cells12020299 · Cited by 23
Aggarwal, T., Wadhwa, R., Thapliyal, N., Sharma, K., Rani, V., & Maurya, P. K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27181 · Cited by 22
Role of nutraceuticals in respiratory and allied diseases
Gulati, K., Verma, P., Rai, N., & Ray, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00007-0 · Cited by 24
Ma, Y., Luo, L., Liu, X., Li, H., Zeng, Z., He, X., Zhan, Z., & Chen, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107593 · Cited by 18
Oxidants in Acute and Chronic Lung Disease
Mannam, P. (2014) · Journal of Blood & Lymph · doi:10.4172/2165-7831.1000128 · Cited by 18
Pengaruh Radikal Bebas Terhadap Proses Inflamasi pada Penyakit Paru Obstruktif Kronis (PPOK)
Suryadinata, R. V. (2018) · Amerta Nutrition · doi:10.20473/amnt.v2i4.2018.317-324 · Cited by 22
Sun, X., Shang, J., Wu, A., Xia, J., & Xu, F. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14852 · Cited by 16
Dalle‐Donne, I., Colombo, G., Gornati, R., Garavaglia, M. L., Portinaro, N. M., Giustarini, D., Bernardini, G., Rossi, R., & Milzani, A. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6772 · Cited by 16
Cui, H., Liu, X., Zhang, J., Zhang, K., Yao, D., Shi, D., Feng, S., Yang, L., Li, Y., Wang, H., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6103158 · Cited by 14
A Simple and Sensitive Inhibitory Kinetic Method for the Carbocisteine Determination
Srivastava, A., Sharma, V., Singh, V. K., & Srivastava, K. (2021) · Journal of the Mexican Chemical Society · doi:10.29356/jmcs.v66i1.1654 · Cited by 14
Challenges in the management of asthma associated with smoking-induced airway diseases
Thomson, N. C. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1515912 · Cited by 14
2,2′-Azobis (2-Amidinopropane) Dihydrochloride Is a Useful Tool to Impair Lung Function in Rats
Moreira-Gomes, M. D., Carvalho, G. M. C., Casquilho, N. V., Araujo, A. C. P., Valença, S. S., Leal‐Cardoso, J. H., & Zin, W. A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00475 · Cited by 15
Yadav, R. K., Tripathi, C. B., Saraf, S. A., Ansari, M. N., Saeedan, A. S., Aldossary, S. A., Rajinikanth, P. S., & Kaithwas, G. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114628 · Cited by 13
The role of sulfur compounds in chronic obstructive pulmonary disease
Jiang, S., & Chen, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.928287 · Cited by 12
Iqbal, S., Jabeen, F., Aslam, N., & Manan, M. (2023) · Human & Experimental Toxicology · doi:10.1177/09603271231178015 · Cited by 12
Santiago, A., & Morano, K. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102424 · Cited by 13
Altraja, S., Mahlapuu, R., Soomets, U., & Altraja, A. (2012) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2012.09.005 · Cited by 12
Srinivasamurthy, S. K., Mittal, P., Goyal, A., Ballal, S., Maharana, L., Goyal, K., Rana, M., Ali, H., Oliver, B. G. G., Paudel, K. R., et al. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127766 · Cited by 12
Inhibition of TNF-α sepsis of lipopolysaccharide induction using nano cerium oxide system
Ge, L., Hu, Q., Chen, J., Shi, M., Yang, H., & Zhu, G. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.03.207 · Cited by 11
Fan, L., Chen, R., Li, L., Liang, Z., Yu, X., Huang, K., Yin, S., Wu, L., Chen, Y., Xu, Y., et al. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/4265790 · Cited by 11
Crosstalk Between Co-cultured A549 Cells and THP1 Cells Exposed to Cigarette Smoke
Hołownia, A., Wielgat, P., Kwolek, A., Jackowski, K., & Braszko, J. J. (2015) · Advances in experimental medicine and biology · doi:10.1007/5584_2015_112 · Cited by 11
Farrell, L. A., O’Rourke, M. B., Padula, M. P., Souza-Fonseca-Guimarães, F., Caramori, G., Wark, P. A. B., Dharmage, S. C., & Hansbro, P. M. (2024) · Proteomes · doi:10.3390/proteomes12030023 · Cited by 12
Cui, Y., Yang, Z., Lv, Z., & Lei, J. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166842 · Cited by 11
Oxidative Signaling in Chronic Obstructive Airway Diseases
Thimraj, T. A., George, L., Asrafuzzaman, S., Upadhyay, S., & Ganguly, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805417-8.00007-x · Cited by 9
Babic, M., Veljović, K., Popović, N., Golić, N., Radojkovic, D. P., & Stankovic, M. M. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad257 · Cited by 8
Lyn Regulates Cytotoxicity in Respiratory Epithelial Cells Challenged by Cigarette Smoke Extracts
Wang, W., Ye, Y., Li, J., Li, X., Zhou, X., Tan, D., Jin, Y., Wu, E., Cui, Q., & Wu, M. (2014) · Current Molecular Medicine · doi:10.2174/1566524014666140603095027 · Cited by 8
Ahmed, R. G., Incerpi, S., Ahmed, F., & Gaber, A. (2013) · Journals & Books Hosting (International Knowledge Sharing Platform) · Cited by 7
Extrapulmonary effects of temporal exposure to cigarette smoke
Martins, T. L., Campos, K. K. D., Araújo, N. P. D. S., Machado, D. F., & Bezerra, F. S. (2017) · Toxicology and Industrial Health · doi:10.1177/0748233717715187 · Cited by 8
Liu, Y., Dou, G.-J., Xiao, Y., Chen, X., Wei, L., & Zhou, W. (2024) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2024.2403611 · Cited by 6
Liu, C.-C., Chen, Y.-H., Chang, Y.-H., Chien, W., Lin, H., Cheng, C.-G., & Cheng, C. (2022) · Healthcare · doi:10.3390/healthcare10020381 · Cited by 6
Animal models for anti-emphysema drug discovery
Gardi, C., Stringa, B., & Martorana, P. A. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1016871 · Cited by 5
Janetzki, J. L., Sykes, M. J., Ward, M., & Pratt, N. L. (2023) · Drug Safety · doi:10.1007/s40264-023-01374-5 · Cited by 4
Joy, M. N., Коvalev, I. S., Shabunina, O. V., Santra, S., & Zyryanov, G. V. (2024) · Antioxidants · doi:10.3390/antiox13101198 · Cited by 5
Jeong, J.-S., Kim, J., Kim, J., Kim, C.-Y., Ko, J., & Kim, T. (2023) · Nutrients · doi:10.3390/nu15020253 · Cited by 4
Smoking, Oxidative/Carbonyl Stress, and Regulation of Redox Signaling in Lung Inflammation
Sundar, I. K., Yao, H., Kirkham, P., & Rahman, I. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_65 · Cited by 4
Self-citationIosr, P., & Bai, M. M. B. M. M. (2014) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.6084/m9.figshare.1041288.v1 · Cited by 3
New markers in chronic obstructive pulmonary disease
Akdeniz, Y. S., & Özkan, S. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.06.001 · Cited by 4
Samuel, S., Suradi, S., & Sutanto, Y. S. (2019) · Jurnal Respirologi Indonesia · doi:10.36497/jri.v39i3.63 · Cited by 2
Sutanto, Y. S., ., S., & Samuel, S. (2019) · KnE Life Sciences · doi:10.18502/kls.v4i12.4160 · Cited by 1
Effects of vitamin D on inflammation and oxidative stress in airway epithelial cells
Norton, R. (2012) · UEA Digital Repository (University of East Anglia) · Cited by 1
Metadata
- Authors
- Rahman, I.
- Affiliations
- University of Rochester Medicine (US)
- Corresponding author
- Rahman, Irfan
- ORCID
- Rahman, Irfan
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 1822
- Issue
- 5
- Pages
- 714-728
- ISSN
- 0925-4439 (ISSN-L)
- PMC
- PMC3295924
- OpenAlex
- W2123397711
- Cited by
- 117
- References
- 192
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 7 · 2023: 10 · 2022: 8 · 2021: 10 · 2020: 3 · 2019: 6 · 2018: 9 · 2017: 10 · 2016: 8 · 2015: 8 · 2014: 16 · 2013: 10 · 2012: 7
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- National Institutes of Health (5r01hl097751-04, ES01247, 1R01HL097751)
- National Heart, Lung, and Blood Institute (1R01HL097751, R01HL092842, R01-HL097751, R01HL085613)
- National Institute of Environmental Health Sciences (ES-01247, P30ES001247)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- chronic obstructive pulmonary disease, antioxidants, oxidative stress, carbonyl stress, thiols, glutathione, N-acetylcysteine, erdosteine, ergothioneine, carbocysteine, spin traps, superoxide dismutase mimetic, porphyrins, edaravone, lazaroids, tirilazad, NF-κB, inflammation, cigarette smoke, biomass fuel, lipid peroxidation, antioxidant therapeutics
- MeSH terms
- Antioxidants, Humans, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
